Home Ignite Immunotherapy

Ignite Immunotherapy

In operation
-
Cancer Immunotherapy Developer
Basic
Enterprise Profile

Basic Information

Ignite Immunotherapy is committed to unleashing the full potential of cancer immunotherapy. Their optimized intravenous oncolytic cancer vaccine aims to complement approved immune checkpoint inhibitors by stimulating an immune response against patients' cancer. Their goal is to cure cancer patients through combination immunotherapy and intravenous oncolytic vaccines.
Ignite Immunotherapy Inc.
California,United States of America
less than 15 people
January 01, 2016
--
info@igniteimmunotherapy.com

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Technology
Gene Technology Immunological Techniques
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs Traditional Vaccines (Biological Products for Prevention)